Detalhe da pesquisa
1.
O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate for Tau and α-Synuclein Proteinopathies.
ACS Chem Neurosci
; 13(8): 1296-1314, 2022 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35357812
2.
In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
J Neurochem
; 111(2): 614-23, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19702657
3.
Generation and characterization of a rabbit monoclonal antibody site-specific for tau O-GlcNAcylated at serine 400.
FEBS Lett
; 587(22): 3722-8, 2013 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24113653